You are viewing an incomplete version of our website. Please click to reload the website as full version.

BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (N-Term) Peptide

Details for Product No. ABIN1382370, Supplier: Log in to see
Protein Name
  • BIK
  • Biklk
  • Blk
  • Nbk
  • BIP1
  • BP4
  • NBK
  • si:dkey-31f5.6
Protein Region
N-Term
Origin
Human
2
1
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (N-Term) antibody (ABIN1031274)
Characteristics 15 amino acids near the amino terminus of human Bik.
Human
Research Area Apoptosis/Necrosis
Application Notes Bik peptide is used for blocking the activity of Bik.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Kuwata, Watanabe, Jiang et al.: "AIM inhibits apoptosis of T cells and NKT cells in Corynebacterium-induced granuloma formation in mice." in: The American journal of pathology, Vol. 162, Issue 3, pp. 837-47, 2003 (PubMed).

Germain, Mathai, Shore: "BH-3-only BIK functions at the endoplasmic reticulum to stimulate cytochrome c release from mitochondria." in: The Journal of biological chemistry, Vol. 277, Issue 20, pp. 18053-60, 2002 (PubMed).

Haruta, Kato, Hashimoto et al.: "Association of AIM, a novel apoptosis inhibitory factor, with hepatitis via supporting macrophage survival and enhancing phagocytotic function of macrophages." in: The Journal of biological chemistry, Vol. 276, Issue 25, pp. 22910-4, 2001 (PubMed).